DOCSLIB.ORG

Biliary Atresia Splenic Malformation Syndrome: a Single Center Experience

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biliary Atresia Splenic Malformation Syndrome: a Single Center Experience Acta Medica 2019; 36 - 41 acta medica ORIGINAL ARTICLE Biliary Atresia Splenic Malformation Syndrome: A Single Center Experience 1 ABSTRACT Onder Ozden ,[MD] ORCID: 0000-0001-5683-204X Objective: Biliary atresia splenic malformation (BASM) syndrome which is a subgroup of BA is associated with situs inversus, intestinal malrotation, Seref Selcuk Kilic1 MD] ,[ polysplenia, preduodenal portal vein, interrupted vena cava, congenital por- ORCID: 0000-0002-1427-0285 tocaval shunts and cardiac anomalies. We aimed to report our experiences 1 in BASM management and association of CMV infection. Murat Alkan ,[MD] Materials and Methods: The data were collected retrospectively from med- ORCID: 0000-0001-5558-9404 ical records of patients treated in Cukurova University between 2005-2017. Sex, age, liver function tests, serological test results, BA types, surgical find- 2 Gokhan Tumgor ,[MD] ings, and mortality were noted. ORCID: 0000-0002-3919-002X Results: Fifty-nine BA patients were diagnosed in the study period. Seven of them were classified as BASM. The median age was 60 days (45-90 days) 1 Recep Tuncer ,[MD] with a female/male ratio of 3/4. The main complaint of all patients was jaun- ORCID: 0000-0003-4670-8461 dice. The jaundice of 6 patients began since birth and one began at 20 days- age. Median total/direct blood bilirubin levels were 9.6/5.4 mg/dL. Median 1,*Cukurova University Department of Pediatric values of liver function tests; ALT, AST, and GGT were 77 IU/L, 201 IU/L Surgery, Adana, Turkey and 607 IU/L respectively. Five of the patients showed positive results for anti-CMV Ig M. All patients had positive anti-CMV Ig G. One patient had 2 Cukurova University Department of Pediatric type 2 BA and all others had type 3 BA. Associated anomalies were polys- Gastroenterology, plenia (n=4), asplenia (n=1), preduodenal portal vein (n=5), midgut malrota- tion (n=7), inferior vena cava interruption (n=1) and hepatic artery originat- ing from superior mesenteric artery (SMA) (n=1). Patients had Ladd proce- dure (n=7), duodenoduodenostomy (n=5) along with Kasai portoenterosto- my. The median follow-up time was 4 years (1-5 years). All patients are alive * Corresponding Author : Dr. Önder Özden and one had liver transplantation. Conclusion: Patients with BASM represent a distinct subgroup of BA which Cukurova University, Department of Pediatric Surgery may have additional gastrointestinal anomalies such as midgut malrota- Address: Çukurova Üniversitesi Balcalı Hastanesi Çocuk tion and preduodenal portal vein. Thus additional procedures such as du- Cerrahisi Anabilim Dalı 01330 Sarıçam/Adana, Turkey odenoduodenostomy and Ladd procedure may be added to Kasai portoen- Email: [email protected] terostomy. Further research is recommended for CMV infections role in Tel: +905373104769 BASM pathogenesis. Received: 29 April 2019, Accepted: 21 November 2019, Published online: 31 December 2019 INTRODUCTION Biliary atresia (BA) is a rare, progressive, inflamma- is associated with congenital abnormalities, includ- tory disease of the bile ducts. It is a destructive chol- ing situs inversus, intestinal malrotation, polysplen- angiopathy that eventually leads to liver cirrhosis. ia, preduodenal portal vein, interrupted vena cava, The etiology of BA is still unknown and its incidence congenital portocaval shunts, and cardiac anoma- varies between 1/9000 and 1/15000, depending on lies. The incidence of BASM also varies according to the country [1]. Biliary atresia splenic malforma- the country. The incidence of BASM cases among all tion (BASM) syndrome which is a subgroup of BA cases of BA is 5% in China, 10% in England, 13% in 36 © 2019 Acta Medica. All rights reserved. Acta Medica 2019; 36 - 41 Ozden et al. Canada and 5% in Japan [2-5]. aspartate aminotransferase and gamma-glutamyl The Japanese Association of Pediatric Surgeons transferase levels were 77 (53–147) IU/L, 201 (121– classifies BA into 3 types. There is common bile duct 503) IU/L, and 607 (247–780) IU/L, respectively. The atresia with patent proximal bile ducts in type 1 BA. levels of TORCH antibodies in blood were routine- In type 2 BA, the main hepatic, cystic, and common ly evaluated by performing immunohistochemical bile ducts are atretic with patent right and left he- analysis in all jaundiced patients. Five of the patients patic ducts. Finally, in type 3 BA, the intrahepat- showed positive results for anti-CMV immunoglob- ic bile ducts are also atretic. Another classification ulin M. All patients showed positive results for an- scheme according to Davenport, divides BA into 4 ti-CMV IgG and anti-toxoplasma IgG. All other sero- clinical groups. These are syndromic BA, cystic BA, logical tests revealed normal results. CMV-associated BA, and isolated BA. In this classifi- One patient had type 2 BA and all others had type cation system, BASM is a subgroup of syndromic BA 3 BA. [6]. Surgical findings were used for the diagnosis of There is a well-established association between BA BASM. Further analysis of these findings revealed and cytomegalovirus (CMV) infection, and such cas- that four of the seven patients had polysplenia, one es are termed as CMV associated BA. had asplenia, (Figure 1). Five patients had preduo- In this study, we aimed to present our data with spe- denal portal vein (Figure 2) and underwent duode- cial emphasis on additional interventions such as noduodenostomy. All patients had midgut malrota- duodenoduodenostomy in cases with preduodenal tion and they had Ladd procedure. One patient had portal vein and Ladd procedure in midgut malrota- inferior vena cava interruption and one had a he- tion besides association of BASM and CMV infection. patic artery originating from the superior mesenter- ic artery. All patient data has been summarized in MATERIALS and METHODS Table 1. The median time of follow-up was 4 years (1-5 years). All patients survived and 1 had a liver Medical records of patients who were diagnosed as transplantation. BA between 2005 and 2017 were evaluated. Patients with BA were included in the study if they had one DISCUSSION of the following anomalies: asplenia, polysplenia, heterotaxy syndrome, inferior vena cava portal vein Twenty-five percent of BA cases are of the BASM anomalies, intestinal rotational anomalies, and car- subtype, which involves splenic malformations. diac anomalies. Patients with an association of BA Other anomalies are situs inversus, intestinal mal- and other common congenital abnormalities (unde- rotation, preduodenal portal vein, interrupted vena scended testis, hypospadias) were excluded. The pa- cava, congenital portocaval shunts, cardiac anom- tient’s sex, age, liver function tests, serological tests alies, and central nervous system anomalies [14]. A of Toxoplasma infection, syphilis, varicella-zoster, major component of BASM is polysplenia. Not all parvovirus B19, Rubella, CMV and Herpes (TORCH) patients have polysplenia or splenic malformation infections in the blood, BA type, surgical findings, and the term “biliary atresia congenital structur- and mortality were retrospectively analyzed. al anomalies” has been used instead but not wide- ly accepted [7]. In this study, we found a BASM inci- RESULTS dence rate of 11%. Two of the patients in our study did not have any splenic malformation. Fifty-nine patients whose diagnose were confirmed The cause of BA is not understood as well as BASM. by operative cholangiography had a surgical inter- BA is destructive biliary fibrosis and the etiology is vention for BA in our institution. Seven of these pa- thought to be multifactorial (genetic, infection, tox- tients (3 girls and 4 boys with a median age of 60 in, immunological). The extrahepatic bile duct orig- days, (45–90 days) were classified as BASM. The ma- inates from the primordial bud of the intestine at jor complaint of all patients was jaundice, with six pa- 5 weeks gestation, followed by normal canaliza- tients exhibiting the symptoms since birth and the tion at 6 weeks. BASM has some component which five with the disease onset at 20-days of age. The me- is definitely congenital such as midgut malrota- dian total/direct blood bilirubin levels were 9.6(8.0- tion, asplenia, polysplenia, hepatic artery anoma- 16.3) mg/dL/5.4 (4.5-7.6) mg/dL. Median values from lies. Therefore, the etiology of BASM may be caused liver function test results alanine aminotransferase, by defective organogenesis which is caused by © 2019 Acta Medica. All rights reserved. 37 Biliary Atresia Splenic Malformation Syndrome Figure 1. Polysplenia of patient 4. Figure 2. Preduodenal portal vein (black arrow), annular pancreas (white arrow) and atretic biliary ducts (red arrow) of patient 4. 38 © 2019 Acta Medica. All rights reserved. Acta Medica 2019; 36 - 41 Ozden et al. Table 1: Components of BAPS Hepatic Patients Age (days), Preduodenal por- Midgut VCI Polysplenia artery B.A. types CMV Ig M No: sex tal vein malrotation Anomaly anomalies 1 64,M + + + + Type 3 + - 2 90,F - - + - Type 2 + - 3 76,M + + + - Type 3 + - 4 70, F + + + - Type 3 - + 5 59,M - - + - Type 3 - - 6 45,F Asplenia + + - type 3 + - 7 50,M + + + - Type 3 + - genetic, infectious or immunological factors in the studies, even though there are several reports on BA early fetal developmental period [8,9]. and CMV infection. One of the important prospec- In their case reports, Makin et al have discussed the tive studies concerning CMV IgM and BA was per- etiology of BASM. Three patients had surgical inter- formed at King’s College Hospital. The researchers vention in early life because of other conditions (je- evaluated and compared 20 CMV IgM-positive and junal atresia and duodenal atresia). They observed 111 CMV IgM-negative patients. One of the 20 CMV BASM, but only took liver biopsies since enteral IgM-positive and 17 of the 111 CMV IgM-negative feeding was a higher priority and liver morphology patients studied, had BASM.
Load more

Recommended publications
  • Guideline for the Evaluation of Cholestatic Jaundice
    CLINICAL GUIDELINES Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition ÃRima Fawaz, yUlrich Baumann, zUdeme Ekong, §Bjo¨rn Fischler, jjNedim Hadzic, ôCara L. Mack, #Vale´rie A. McLin, ÃÃJean P. Molleston, yyEzequiel Neimark, zzVicky L. Ng, and §§Saul J. Karpen ABSTRACT Cholestatic jaundice in infancy affects approximately 1 in every 2500 term PREAMBLE infants and is infrequently recognized by primary providers in the setting of holestatic jaundice in infancy is an uncommon but poten- physiologic jaundice. Cholestatic jaundice is always pathologic and indicates tially serious problem that indicates hepatobiliary dysfunc- hepatobiliary dysfunction. Early detection by the primary care physician and tion.C Early detection of cholestatic jaundice by the primary care timely referrals to the pediatric gastroenterologist/hepatologist are important physician and timely, accurate diagnosis by the pediatric gastro- contributors to optimal treatment and prognosis. The most common causes of enterologist are important for successful treatment and an optimal cholestatic jaundice in the first months of life are biliary atresia (25%–40%) prognosis. The Cholestasis Guideline Committee consisted of 11 followed by an expanding list of monogenic disorders (25%), along with many members of 2 professional societies: the North American Society unknown or multifactorial (eg, parenteral nutrition-related) causes, each of for Gastroenterology, Hepatology and Nutrition, and the European which may have time-sensitive and distinct treatment plans. Thus, these Society for Gastroenterology, Hepatology and Nutrition. This guidelines can have an essential role for the evaluation of neonatal cholestasis committee has responded to a need in pediatrics and developed to optimize care.
    [Show full text]
  • Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017
    Appendix 3.1 Birth Defects Descriptions for NBDPN Core, Recommended, and Extended Conditions Updated March 2017 Participating members of the Birth Defects Definitions Group: Lorenzo Botto (UT) John Carey (UT) Cynthia Cassell (CDC) Tiffany Colarusso (CDC) Janet Cragan (CDC) Marcia Feldkamp (UT) Jamie Frias (CDC) Angela Lin (MA) Cara Mai (CDC) Richard Olney (CDC) Carol Stanton (CO) Csaba Siffel (GA) Table of Contents LIST OF BIRTH DEFECTS ................................................................................................................................................. I DETAILED DESCRIPTIONS OF BIRTH DEFECTS ...................................................................................................... 1 FORMAT FOR BIRTH DEFECT DESCRIPTIONS ................................................................................................................................. 1 CENTRAL NERVOUS SYSTEM ....................................................................................................................................... 2 ANENCEPHALY ........................................................................................................................................................................ 2 ENCEPHALOCELE ..................................................................................................................................................................... 3 HOLOPROSENCEPHALY.............................................................................................................................................................
    [Show full text]
  • Newborn Handbook
    Pediatric Residency Newborn Handbook 2020-2021 1 Table of Contents Topic Page Contact Information 3 Routine Newborn Care 4 Discharge Talk Guidelines 5-7 AAP Recommendations for Healthy Term Newborn Discharge Criteria 8-9 Basic management of maternal labs/risk factors and Medication Refusal 10-11 Routine Vitamin K Prophylaxis 12 Hep B Vaccine Information and Management of Maternal Hepatitis B Status 13 Routine Erythromycin Prophylaxis for Ophthalmia Neonatorum 14 Hearing Screen 15 CCHD Screening 16 Michigan Newborn Screening 17 Breast Feeding 18-19 Infant feeding policy (donor breast milk) 20 Ankyloglossia and Frenotomy 21 Circumcision 22 Car Seat Safety 23-24 Nursery Protocols 25 Locating Policies, Procedures & Protocols 25 NRP (Neonatal Resuscitation Protocol), APGAR Scoring, MR. SOPA 26 Indirect Hyperbilirubinemia 27-30 Hypoglycemia Algorithm 31-32 Hypoglycemia Treatment, SGA & LGA cutoffs, and Pounds to Kilogram Conversion 33 Chorioamnionitis protocol and antibiotic duration, GBS Algorithm 34-35 Temperature Regulation 36-38 On-Call Problems & a note about SBARs 39 Respiratory/Cardiovascular Respiratory Distress 40-41 Cyanosis 42 Heart Murmurs, Cardiac Exam, and CHD 43 FEN/GI/Endo: Newborn Fluid Management and Weight Specific Guidelines for Feeding 44 Bilious Vomiting 45-46 When You’re Asked About the Appearance of Baby Poop 47 Bloody Stool 48 No stool in 48 hours of life and No void in 30 hours of life 49 Maternal Graves’ Disease 50 Renal Management of Antenatal Hydronephrosis 51 HEENT/Neuro Skull Sutures & Fontanels / Extracerebral Fluid Collections/Subgaleal Hemorrhage 52-53 Infant Fall 54 Oral-facial clefts 55-56 Neonatal Seizures 57 Neonatal Abstinence Syndrome 58-60 Infectious Disease Rubella, CMV, HIV 61 Syphillis 62-63 Toxoplasmosis, HSV 64 Recommended HSV management 64-67 Hepatitis C, Varicella 67 Assessing Gestational Age and the Ballard Score 68 Selected Lab Evaluation 69 Transferring to NICU 70 2 Contact Information Resident ASCOM: 76087.
    [Show full text]
  • Hypertrophic Pyloric Stenosis
    Arch Dis Child: first published as 10.1136/adc.58.12.1035 on 1 December 1983. Downloaded from Correspondence 1035 and in 7 of 9 patients with intrahepatic cholestasis, Changing incidence of infantile proving a poor discriminatory test. As ultrasound is safe, non-invasive, and does not hypertrophic pyloric stenosis depend on hepatobiliary function we routinely use it to screen all cholestatic patients before proceeding to liver Sir, biopsy or laparotomy as required. The papers from Birmingham1 and from South Wales2 show an increased incidence of pyloric stenosis. The P SHAW AND D A KELLY authors have various suggestions for this increase; but Departments ofPaediatrics and Medicine, is it anything more than better diagnosis? In most Royal Free Hospital, paediatric units the decision to operate is made on the Pond Street, basis of a convincing history and the finding of a palpable London NW3 pyloric mass. Over the years I have been amazed that, even at times when I have been a little doubtful about the presence of such a pyloric mass, surgeons at operation have always found hypertrophic pyloric stenosis and Drs Mowat Hylton, and Meire comment: performed a Ramstedt's operation. This must mean that, in general, I and perhaps other paediatricians are under- All infants with conjugated hyperbilirubinaemia ad- believe mitted to our unit have ultrasound examination before diagnosing pyloric stenosis, because I cannot If dilated extrahepatic ducts are found, that for any condition I am 100% correct. liver biopsy. In the last 10 years there has been a great increase in laparotomy for presumed choledochal cyst is considered staff in without prior liver biopsy.
    [Show full text]
  • ED368492.Pdf
    DOCUMENT RESUME ED 368 492 PS 6-2 243 AUTHOR Markel, Howard; And Others TITLE The Portable Pediatrician. REPORT NO ISBN-1-56053-007-3 PUB DATE 92 NOTE 407p. AVAILABLE FROMMosby-Year Book, Inc., 11830 Westline Industt.ial Drive, St. Louis, MO 63146 ($35). PUB TYPE Guides Non-Classroom Use (055) Reference Materials Vocabularies/Classifications/Dictionaries (134) Books (010) EDRS PRICE MF01/PC17 Plus Postage. DESCRIPTORS *Adolescents; Child Caregivers; *Child Development; *Child Health; *Children; *Clinical Diagnosis; Health Materials; Health Personnel; *Medical Evaluation; Pediatrics; Reference Materials; Symptoms (Individual Disorders) ABSTRACT This ready reference health guide features 240 major topics that occur regularly in clinical work with children nnd adolescents. It sorts out the information vital to successful management of common health problems and concerns by presentation of tables, charts, lists, criteria for diagnosis, and other useful tips. References on which the entries are based are provided so that the reader can perform a more extensive search on the topic. The entries are arranged in alphabetical order, and include: (1) abdominal pain; (2) anemias;(3) breathholding;(4) bugs;(5) cholesterol, (6) crying,(7) day care,(8) diabetes, (9) ears,(10) eyes; (11) fatigue;(12) fever;(13) genetics;(14) growth;(15) human bites; (16) hypersensitivity; (17) injuries;(18) intoeing; (19) jaundice; (20) joint pain;(21) kidneys; (22) Lyme disease;(23) meningitis; (24) milestones of development;(25) nutrition; (26) parasites; (27) poisoning; (28) quality time;(29) respiratory distress; (30) seizures; (31) sleeping patterns;(32) teeth; (33) urinary tract; (34) vision; (35) wheezing; (36) x-rays;(37) yellow nails; and (38) zoonoses, diseases transmitted by animals.
    [Show full text]
  • PEDS ABDOMEN General Surgery Seminar
    General Surgery PEDS ABDOMEN General Surgery Seminar Martina Mudri Dr. Andreana Bütter September 7, 2016 Case 1 A 2800g female is born via SVD at 38 weeks gestation. Vitals: T 37, HR 158, BP 80/50, RR 40. She has an abdominal wall defect. The bowel is thickened, edematous, and friable. Case 1 What kind of defect is this? Gastroschisis What are the associated anomalies? None. 10% of babies have bowel abnormalities such as atresia and stenosis. These are related to the bowel trauma and position in utero. Case 1 What are the initial steps in managing this patient after delivery? ABCs Insert NG/OG Cover bowels with saline soaked gauze and plastic Administer IV fluids, Abx Maintain normothermia Case 1 What are the surgical management options? 1.Primary closure in OR. Risk of abdominal compartment syndrome. 2.Umbilical cord flap. Temporary coverage. 3.Placement of silastic silo. This will prevent heat/water losses and keep bowel in sterile environment. Silo tightened over time to slowly reduce bowel. Case 1 When would you proceed directly to the OR? - Closing gastroschisis: defect closes around viscera causing ischemia and infarction Case 1 You have repaired the defect primarily and the baby was started on TPN. 3 weeks later, the NG is still draining 60 cc bile per day. The baby has not passed meconium. What do you do next? A. Observation without intervention B. Upper GI series C. Contrast enema D. Gastric emptying study E. Initiate oral feeds Case 1 You have repaired the defect primarily and the baby was started on TPN.
    [Show full text]
  • Excluded Conditions
    Medical Diagnoses Not an Established Condition - 3 - Not an Established Condition 3-Methylcrotonyl-Coenzyme A (CoA) Carboxylase Deficiency 33-34 weeks EGA (if the birth weight is >1325 grams or 2 lbs 15 oz) 3rd Nerve Palsy (aka: Third Nerve Palsy; Third Cranial Nerve Palsy; 3rd Cranial Nerve Palsy; Oculomotor Palsy; Oculomotor Nerve Palsy; Cranial Nerve III Palsy) - 6 - Not an Established Condition 6th Nerve Palsy (aka: Abducens palsy; Lateral rectus palsy; Cranial mononeuropathy VI) - A - Not an Established Condition Aarskog-Scott syndrome Abnormal Neurological Exam at Discharge from NICU Absent Septum Pellucidum (aka: Absence Septum Pellucidum, Absent Cavum Septum Pellucidum) Achondroplasia Acute Lymphoid Leukemia (aka: ALL) Adams Oliver Syndrome (aka: AOS; Absence Defect of Limbs, Scalp, and Skull; Congenital Scalp Defects with Distal Limb Reduction Anomalies; Aplasia Cutis Congenita with Terminal Transverse Limb Defects) Adjustment Disorder (as defined within DC:0-3R, and diagnosed by specially-qualified professional) Alagille Syndrome (aka: AHD; Arteriohepatic Dysplasia; Cholestasis with Peripheral Pulmonary Stenosis; Syndromatic Hepatic Ductular Hypoplasia) Albinism (aka Ocular Cutaneous Albinism, Oculocutaneous Albinism, Ocular Albinism) Alcohol-Related Neurodevelopmental Disorder (aka: ARND; Fetal Alcohol Spectrum Disorder; FASD) Alport Syndrome (aka: Hematuria-Nephropathy Deafness; Hemorrhagic Familial Nephritis; Hereditary Deafness and Nephropathy; Hereditary Nephritis With Sensory Deafness; Hereditary Nephritis and Nerve Deafness)
    [Show full text]
  • Duodenal Duplication Cysts - a Case Report of the Oldest Man in Literature
    Case Report World Journal of Surgery and Surgical Research Published: 02 Feb, 2021 Duodenal Duplication Cysts - A Case Report of the Oldest Man in Literature Renato Patrone, PhD1*, Alessandra Conzo2, Chiara Cacciatore2, Marco Filardo2, Luigi Flagiello2, Vincenza Granata3, Francesco Izzo4, Fabio Medas5, Ludovico Docimo6 and 2 Giovanni Conzo 1ICTH, University of Naples, Italy 2Division of General and Oncologic Surgery, Department of Anesthesiologic, Surgical and Emergency Sciences, University of Campania Luigi Vanvitelli, Italy 3Department of Radiology, G. Pascale National Cancer Institute IRCCS, Italy 4Division of Surgical Oncology, G. Pascale National Cancer Institute IRCCS, Italy 5Department of Surgical Sciences, University of Cagliari, Italy 6Division of General, Mini-Invasive and Obesity Surgery, Master of Coloproctology and Master of Pelvi-Perineal Rehabilitation, University of Study of Campania Luigi Vanvitelli, Italy Abstract In the cluster of the congenital malformation of gastrointestinal system there is visceral duplication. This is a rare development abnormality that occurs mainly in infant and children and is detected for symptoms related to obstruction or to gastrointestinal bleeding. Only 30% of cases are diagnosed in adult. In Literature, is reported from 1 out of 25,000 to 1 out 100,000 deliveries of duplication of gastrointestinal system, but duodenum duplications are less than 5% of all. Duodenal duplication cysts are usually located in the second or the third part of duodenum, and can communicate with duodenal lumen or be extended into posterior mediastinum, communicate with gall bladder or communicate with the pancreaticobiliary duct. We reported the case of a 70 years-old-man (the oldest one in literature) with a duodenal duplication cyst, his treatment and his outcome.
    [Show full text]
  • Alagille Syndrome: Pathogenesis, Diagnosis and Management
    European Journal of Human Genetics (2012) 20, 251–257 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg PRACTICAL GENETICS In association with Alagille syndrome: pathogenesis, diagnosis and management Alagille syndrome (ALGS), also known as arteriohepatic dysplasia, is a multisystem disorder due to defects in components of the Notch signalling pathway, most commonly due to mutation in JAG1 (ALGS type 1), but in a small proportion of cases mutation in NOTCH2 (ALGS type 2). The main clinical and pathological features are chronic cholestasis due to paucity of intrahepatic bile ducts, peripheral pulmonary artery stenosis, minor vertebral segmentation anomalies, characteristic facies, posterior embryotoxon/anterior segment abnormalities, pigmentary retinopathy, and dysplastic kidneys. It follows autosomal dominant inheritance, but reduced penetrance and variable expression are common in this disorder, and somatic/germline mosaicism may also be relatively frequent. This review discusses the clinical features of ALGS, including long-term complications, the clinical and molecular diagnosis, and management. In brief (4) The diagnosis is essentially clinical, dominated by the con- sequences of bile duct paucity – chronic cholestasis – and (1) Alagille syndrome (ALGS) is a complex autosomal congenital heart disease. dominant disorder due to defects in the Notch signalling (5) Almost 90% of cases are due to mutations in JAG1 (20p12), pathway. an additional 5–7% are due to deletions incorporating JAG1, (2) The main body systems involved are the liver, heart, skele- and about 1% is due to mutations in NOTCH2 (1p13). ton, face and eyes, but penetrance is variable, both within ALGS may be referred to as type 1 (JAG1-associated) or type and between families.
    [Show full text]
  • Kasai Procedure Liver Transplantation
    Biliary Atresia Anna M. Banc-Husu, MD Division of Gastroenterology, Hepatology and Nutrition | Ann & Robert H. Lurie Children’s Hospital of Chicago | 225 East Chicago Avenue, Chicago, IL 60611 What is biliary atresia? What causes biliary atresia? How is biliary atresia treated? • Biliary atresia (BA) is a liver disease of infancy that is the • The cause of biliary atresia is unknown. Kasai Procedure • Blocked bile ducts are leading cause of pediatric liver transplantation. (hepatoportoenterostomy) • Research is currently underway to find the exact cause of removed and a piece of small • Biliary atresia is characterized by destruction of the bile biliary atresia. Several explanations exist including: intestine is connected to the ducts both inside and outside of the liver. o Some trigger (possible virus or environmental toxin) liver to allow direct flow of • Bile ducts normally carry bile from the liver to the causes one’s own immune system to attack ‘self’ bile from the liver. gallbladder, and eventually into the intestines. components of the bile ducts • Bile is composed of waste and other products • Best outcome if performed necessary for digestion and absorption of nutrients. o Abnormalities in the formation and organization of the before 45 days of life. bile ducts early on in development It’s accumulation in the liver is toxic. • If performed after 3 months o Predisposing genetic factors • In biliary atresia, these bile ducts are damaged leading to of age, only 25% of infants accumulation of bile, damage to the liver cells, and eventual will have successful drainage scarring of the liver called cirrhosis. How is biliary atresia diagnosed? of bile.
    [Show full text]
  • Tennessee Birth Defects 2006-2010 Report
    TENNESSEE Birth Defects 2006-2010 OCTOBER 2013 TENNESSEE DEPARTMENT OF HEALTH DIVISION OF POLICY, PLANNING AND ASSESSMENT Tennessee Department of Health Organization John J. Dreyzehner, MD, MPH, Commissioner Bruce Behringer, MPH, Deputy Commissioner David Reagan, MD, Chief Medical Officer Lori B. Ferranti, MSN, MBA, PhD, Director, Division of Policy, Planning and Assessment The mission of the Department of Health is to protect, promote and improve the health and prosperity of people in Tennessee. Tennessee Birth Defects 2006-2010 was prepared by The Tennessee Department of Health, Division of Policy, Planning and Assessment, Office of Health Statistics Authorization No. 343924 (10-13) website only i Table of Contents Executive Summary…………………………….. ………….…..……………………………………1 Birth Defects Overview………………………….. .....….…………………………………………...2 Tennessee Birth Defects Registry……………….. ……..………………………………………..…2 Birth Defects Definition………………………….. ….…………………………………………….…3 Data Sources…………………………………………. …………………………………………….…4 Data Limitation………………………………………. …………………………………………….…4 Data Tables……………………………………….…. …………………………………………….…6 Overall Tennessee Birth Defects Rates………..…. …………………………………………….…7 Birth Defects by Infant Gender……………….…………………………… ……………...………..17 Birth Defects by Infant Race\Ethnicity...............… ...……………………………………………..17 Birth Defects By Perinatal Region……………… …………………………………………………17 Birth Defects by Maternal Age Group…...…….. ….…………………………………………….18 Birth Defects by Maternal Education…....……... .….…………………………………………….18 Birth Defects by Maternal
    [Show full text]
  • Two-Dimensional Ultrasonographic Prenatal Diagnosis of Choledochal
    Case Report iMedPub Journals Gynecology & Obstetrics Case Report 2016 http://www.imedpub.com/ Vol.2 No.2:21 ISSN 2471-8165 DOI: 10.21767/2471-8165.1000021 Two-Dimensional Ultrasonographic Prenatal Diagnosis of Choledochal Cyst: Our Experience and Literature Review Marialuigia Spinelli*, Di Meglio Lavinia, Luigi Raio, Francesco Di Fabrizio, De Ville De Goyet Jean and Daniel Surbek Department of Clinical Research, Prenatal Medicine, University of Bern, Switzerland *Corresponding author: Marialuigia Spinelli, Department of Clinical Research, Prenatal Medicine, University of Bern, Switzerland, Tel: +41(0)316318111; E-mail: [email protected] Received date: April 02, 2016; Accepted date: May 24, 2016; Published date: May 26, 2016 Citation: Spinelli M, Lavinia DM, Raio L, et al. Two-Dimensional Ultrasonographic Prenatal Diagnosis of Choledochal Cyst: Our Experience and Literature Review, Gynecol Obstet Case Rep. 2016, 2:2. Japanese population [2]. CC type 1 is the most commonly clinical presentation (70-90%), and results in most cases from a Abstract malformation of the common junction between the bile duct and the pancreatic duct (at the level of the duodenal wall Choledochal cyst is an abnormality of the biliary ducts, where they join to form a (usually very short) common characterized by a dilatation of a portion of the biliary channel) [1]. ductal system (most commonly a portion or the whole of the extrahepatic bile duct system) that presents usually at Because of the advance and widespread use of ultrasonography as a cystic mass in the right upper ultrasonography (US), CC is nowadays diagnosed frequently in quadrant abdomen. Ultrasonographic prenatal diagnosis infancy or early childhood before symptoms appear, and even may be challenging since the detection of any intra- can be recognized in the antenatal period with maternal US.
    [Show full text]